INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

74,196 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
687 sh
Sep 16, 2026
Page 402 of 1855
← PrevNext →
Sep 18, 2026
traded Sep 16, 2026
+2d
SEC Form 4

Evidence

5
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Tax withholding
F$24K
341 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
1,158 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,547 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
490 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,133 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,465 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,416 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,133 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
VL
von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner
DUOLDuolingo, Inc.
Derivative conversion · 10b5-1 plan
C$332K
23.0K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
687 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
885 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,465 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,888 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
352 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$62K
2,000 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

5
AD
Aufderhaar DavidChief Financial Officer
SFIXStitch Fix, Inc.
Option exercise
M—
43.9K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
352 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
606 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,519 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
FJ
Fitzpatrick JenniferCLO and Head of Program Mgmt.
SIONSionna Therapeutics, Inc.
Grant or award
A—
28.1K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

5
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$123K
4,035 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

5
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
4,042 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$13K
177 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,888 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
567 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Tax withholding
F$43K
608 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M$12K
400 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

5
FJ
Fitzpatrick JenniferCLO and Head of Program Mgmt.
SIONSionna Therapeutics, Inc.
Grant or award
A—
103.1K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

5
MJ
Mettler JodyChief Operating Officer
BTGOBITGO HOLDINGS, INC.
Grant or award
A—
200.0K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$56K
600 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

5
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$193K
16.5K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,493 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
400 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

5
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Gift
G—
945 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
KE
Kleiser Kirk E.Director
CLSTCatalyst Bancorp, Inc.
Option exercise
M—
16.9K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
900 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
KE
Kleiser Kirk E.Director
CLSTCatalyst Bancorp, Inc.
Option exercise
M$6,390
529 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
885 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,472 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence